The authors conducted a review of the major aspects of progression of knowledge about the surgical treatment of hyperparathyroidism.
INTRODUCTION

Hyperparathyroidism is a condition in which
there is an abnormal increase in the levels of parathyroid hormone (PTH), responsible for regulating the level of blood calcium and phosphate. The most common cause of hyperparathyroidism, seen in about 80% of cases, is the primary gland dysfunction due to an adenoma. Multiple adenomas or hyperplasia of the parathyroid glands are diagnosed in the remaining patients. Rarely the cause of hyperparathyroidism is a result of a parathyroid carcinoma. It is a disease for which therapy may be surgical, which involves the removal of the affected gland. When surgery is indicated in patients without prior treatment, the cure rate approaches 95% 1 . In cases where the initial operation is not successful, new surgical explorations become necessary, greatly increasing the number of complications and decreasing success rates to about 80% 2 . Therefore, regardless of the hyperparathyroidism origin, the surgeon who will treat these patients must indisputably have skill, experience and technical knowledge to obtain satisfactory results. Currently, advances in the identification of the glands through preoperatively performed diagnostic tests greatly facilitated parathyroid glands surgery. Frozen section biopsies 3 , intraoperative measurement of PTH levels 4 and less invasive procedures 5 allow great improvement in patients' quality of life 6 .
However, the identification of the parathyroid glands, the recognition of their important role and the understanding of diseases that affect them traveled a long journey to the present state of knowledge. Since inception, the history of the parathyroid glands is full of incidental findings, often the case in medical history.
The aim of this study is to provide the reader with a historical review of the discoveries fundamental to the understanding of the parathyroid glands and to discuss the current role and future prospects of surgery for the treatment of hyperparathyroidism.
ANATOMY OF THE PARATHYROIDS
The parathyroid glands originate from the third and fourth pharyngeal pouches and are usually located next to the thyroid gland. They more commonly lie adjacent to the capsule at the posterior face of the thyroid, two on the upper pole and two on the lower, although . In a detailed way, he described coloration, shape, variations in the location of glands and held a detailed microscopic analysis. As his report was a long one, about 50 pages, the editors of the time rejected it, and he managed to publish their findings long after, and only in his mother tongue 10 . The description in a little widespread language, associated with lack of understanding about the function these small glands, In 1891, the French physiologist Eugene Gley, when testing in rats, rabbits and dogs, described that tetany occurred after thyroidectomy only if the glands described by Sandström were also removed. Subsequently he confirmed that removal of the parathyroids alone caused the same effect. Based on these findings, he recommended extreme caution to surgeons to avoid damaging the parathyroid glands in thyroidectomy and was probably the first to define the essential character of these glands, although not clearly identifying their functions 9 . That same year, Friedrich von Recklinghausen, a famous German pathologist, first described a condition characterized by widespread decalcification of the skeleton, associated with the formation of cysts in the bones, which he called fibrocystic bone disease, without identifying the source of dysfunction. When evaluating that patient, he described the increase of a parathyroid gland, but he did not establish a causal relationship between the findings 9 . Max Askanazy, in 1903 18 , described a tumor in the parathyroid in autopsies on patients who had died with the condition described by von Recklinghausen, though also failing to establish the relationship between the two findings. In the early twentieth century, it became clear that parathyroid removal or ischemia caused tetany. Nevertheles, the main hypothesis was that the glands were responsible for the removal of unknown human body toxins.
The first evidence of the relationship between the parathyroid and calcium metabolism arose in 1907, when Jakob Erdheim, an Austrian pathologist who studied the parathyroid glands in patients with bone disease, noted that many patients with bone diseases such as osteomalacia and osteitis fibrosa had increased parathyroids.
Unfortunately, he erroneously believed that the glands increase was a compensatory response caused by bone disease. That same year, Erdheim reported the diagnosis of a patient with two simultaneous tumors, one in the parathyroid gland and the other in the pituitary, an omen of the multiple endocrine neoplasia that would be described more than 50 years later. The determination of serum calcium levels, from 1909, finally allowed the association between this ion and the parathyroid glands.
William MacCallum 19 was the first to describe the improvement of tetany in animals with the instillation of a parathyroid extract. As a complement to these studies, he also pioneered the evidence that post-parathyroidectomy tetany could be corrected with calcium injection.
Despite the inconsistency of his results, he was one of the first to suggest that the cause of tetany was related to low levels of serum calcium. These data led William
Halsted to initiate the use of calcium and parathyroid
214-222
Toneto The history of the parathyroid surgery extract in his patients with tetany 20 . Only in 1923, Adolf
Hanson, a student at the University of Minnesota, was able to develop a stable and reproducible parathyroid extract from bovine parathyroid 21 . James Collip, a Canadian biochemist, recognized for collaborating in studies to identify insulin, independently developed studies to improve the parathyroid extract and define the best form of administration. In 1925, he proved that tetany and symptoms of hypocalcemia could be appropriately corrected, and obtained the first patent for PTH extract 22 . The review of all those data compiled by Boothby, condensing the knowledge of the time, definitely concluded that the parathyroid function was related to the calcium metabolism 23 .
EARLY SURGERY AND INITIAL MISTAKES
Interestingly, the history of transplants prob- great analysis of 143 patients followed for ten years 34 .
The main findings of this well-conducted study were:
1) there was a great loss to follow-up, both by patients and physicians; 2) lack of consensus on specific monitoring tests; 3) absence of predictive factors for disease activation; and 4) recommendation of surgery by an experienced surgeon (minimum of nine to ten operations per year).
THE TECHNOLOGY ADVANCES FACILITATING PARA-THYROID SURGERY
The success of the aforementioned isolated cases encouraged surgeons to recommend parathyroidectomy as a routine procedure to treat hypercalcemia, soon appearing the first series of cases operated with good results
35
. There was also the realization that hyper- .
214-222
Toneto The history of the parathyroid surgery
FINAL COMMENTS
The parathyroid glands were the last of the endocrine glands to be discovered, this perhaps being one of the reasons that justify the difficulties in the evaluation of patients with hyperparathyroidism in the last century. The history of parathyroid surgery prospered in a way particularly similar to the history of surgery. Knowledge developed slowly from incidental findings, case reports, chance contributions from patients and medical students, laboratory research and, just recently, more well-designed scientific studies.
Patients with hyperparathyroidism may present with a wide spectrum of symptoms, but often are asymptomatic and diagnosis is obtained in a routine examination.
Current well-structured guidelines allow treatment to be well oriented, allowing highly satisfactory success rates. That responsibility lies with the surgeons of today, ensuring a surgical procedure of excellence, in appropriate hospitals.
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